First Trust Nasdaq Pharmaceuticals ETF (FTXH US) stock market data APIs
29.1918
-0.05(-0.2%)
as of October 16, 2025
Try our APIs with
free plan!
First Trust Nasdaq Pharmaceuticals ETF Financial Data Overview
Price chart is built with
Anychart
Prev. Close
29.1918
Open
29.1374
High
29.1374
Low
29.1918
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get First Trust Nasdaq Pharmaceuticals ETF data using free add-ons & libraries
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get First Trust Nasdaq Pharmaceuticals ETF End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
First Trust Nasdaq Pharmaceuticals ETF News
New
ETFs to Watch Post JNJ's Q3 Earnings Surprise & Bullish Outlook
Pharma-giant Johnson & Johnson (JNJ) recently reported better-than-expected third-quarter 2025 results. The drugmaker continued its streak of earnings beat and also beat on sales estimates. The compan...
Generic drug imports unlikely to face tariffs - report
[Tariff health care cost.] The Trump administration isn't planning to impose tariffs on generic drug imports, _The Wall Street Journal _reported, although the move isn't final and could change in the...
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit
On Sept. 25, 2025, President Donald Trump imposed a new set of tariffs on the U.S. economy, including a 100% levy on imported branded and patented pharmaceutical products, effective Oct. 1. This annou...
ETFs to Gain on JNJ's Solid Q1 Earnings & Upbeat Outlook
Johnson & Johnson JNJ reported stronger-than-expected second-quarter 2025 results. The world's biggest healthcare products maker continued with its long streak of earnings beat and also exceeded reven...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
